Mechanism of action of thalidomide in Crohn's disease investigated as part of clinical trial Nov. 30, 2000
Synthetic immunomodulatory peptide inhibits production of proinflammatory cytokines in CD Nov. 29, 2000
PDL demonstrates activity at low doses, safety of HuZAF in humans; plans trials in Crohn's disease Nov. 24, 2000
Recent patent describes synthesis and use of indazole derivatives acting as 5-HT3/5-HT4 antagonists Nov. 23, 2000